Bone Marrow Transplantation - Table of Contents alert Volume 48 Issue 11

Advertisement Frontiers in Oncology benefits from an open access platform and research network that allows you to discuss and disseminate your research and connect with other researchers across your field. Our speciality sections include Stem Cell Research, Cancer Genetics and Surgical Oncology, and are open for submissions of a variety of article types including mini reviews and opinion articles.  Submit your paper today and be a part of the future of research publication TABLE OF CONTENTS Volume 48, Issue 11 (November 2013) In this issue Reviews Special Report Original Articles Letters to the Editor Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Choose Scientific Reports for fast, efficient, open access publishing  94% of authors said they are likely or very likely to recommend Scientific Reports to their colleagues* 91% of authors would publish in Scientific Reports again*  SUBMIT your paper today!  *Nature Publishing Group author survey, data correct as of September 2013 Reviews Top Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative ALL: what should we choose when no HLA-matched related donor is available? S Nishiwaki, Y Atsuta and J Tanaka Bone Marrow Transplant 2013 48: 1369-1376; advance online publication, March 11, 2013; 10.1038/bmt.2013.20 Abstract | Full Text Cellular immunotherapy for plasma cell myeloma A L Garfall, D T Vogl, B M Weiss and E A Stadtmauer Bone Marrow Transplant 2013 48: 1377-1386; advance online publication, May 6, 2013; 10.1038/bmt.2013.54 Abstract | Full Text Special Report Top An update to the HLA Nomenclature Guidelines of the World Marrow Donor Association, 2012 W Bochtler, M Maiers, J N A Bakker, D M Baier, J A Hofmann, J Pingel, H-G Rist, M Oudshoorn, S G E Marsh, C R Müller and C K Hurley on behalf of the Information Technology Working Group of the World Marrow Donor Association, Leiden, The Netherlands Bone Marrow Transplant 2013 48: 1387-1388; advance online publication, July 1, 2013; 10.1038/bmt.2013.93 Abstract | Full Text Original Articles Top CONDITIONING REGIMENS Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) J Tanaka, H Kanamori, S Nishiwaki, K Ohashi, S Taniguchi, T Eto, H Nakamae, K Minagawa, K Miyamura, H Sakamaki, Y Morishima, K Kato, R Suzuki, N Nishimoto, K Oba and N Masauzi Bone Marrow Transplant 2013 48: 1389-1394; advance online publication, May 13, 2013; 10.1038/bmt.2013.68 Abstract | Full Text Reduced intensity-conditioned allogeneic stem cell transplantation for multiple myeloma relapsing or progressing after autologous transplantation: a study by the European Group for Blood and Marrow Transplantation H W Auner, R Szydlo, A van Biezen, S Iacobelli, G Gahrton, N Milpied, L Volin, J Janssen, S Nguyen Quoc, M Michallet, H Schoemans, J el Cheikh, E Petersen, F Guilhot, S Schönland, L Ahlberg, C Morris, L Garderet, T de Witte and N Kröger on behalf of the Plasma Cell Dyscrasia Sub-committee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation (EBMT) Bone Marrow Transplant 2013 48: 1395-1400; advance online publication, May 27, 2013; 10.1038/bmt.2013.73 Abstract | Full Text Reduced-intensity conditioning followed by allogeneic transplantation in pediatric malignancies: a report from the Société Française des Cancers de l’Enfant and the Société Française de Greffe de Moelle et de Thérapie Cellulaire C Paillard, E Rochette, P Lutz, Y Bertrand, G Michel, P Bordigoni, J H Dalle, P Rohrlich, J P Vannier, Y Perel, D Plantaz, G Leverger, A Sirvent, E Dore, F Isfan, E Merlin, B Pereira, P Halle, N Rabiau, J Kanold and F Deméocq Bone Marrow Transplant 2013 48: 1401-1408; advance online publication, June 10, 2013; 10.1038/bmt.2013.82 Abstract | Full Text The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT S P Robinson, C Canals, J J Luang, H Tilly, C Crawley, J Y Cahn, D Pohlreich, S Le Gouill, M Gilleece, N Milpied, M Attal, P Biron, S Maury, A Rambaldi, J Maertens, S Capria, P Colombat, S Montoto and A Sureda Bone Marrow Transplant 2013 48: 1409-1414; advance online publication, June 17, 2013; 10.1038/bmt.2013.83 Abstract | Full Text Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML C Ustun, A C Wiseman, T E DeFor, S Yohe, M A Linden, B Oran, M Burke, E Warlick, J S Miller and D Weisdorf Bone Marrow Transplant 2013 48: 1415-1420; advance online publication, August 12, 2013; 10.1038/bmt.2013.124 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Prospective qualitative and quantitative non-invasive evaluation of intestinal acute GVHD by contrast-enhanced ultrasound sonography E Benedetti, B Bruno, G B McDonald, A Paolicchi, F Caracciolo, F Papineschi, M Pelosini, D Campani, S Galimberti and M Petrini Bone Marrow Transplant 2013 48: 1421-1428; advance online publication, May 13, 2013; 10.1038/bmt.2013.65 Abstract | Full Text Comorbidity burden in patients with chronic GVHD W A Wood, X Chai, D Weisdorf, P J Martin, C Cutler, Y Inamoto, D Wolff, S Z Pavletic, J Pidala, J M Palmer, M Arora, S Arai, M Jagasia, B Storer, S J Lee and S Mitchell Bone Marrow Transplant 2013 48: 1429-1436; advance online publication, May 13, 2013; 10.1038/bmt.2013.70 Abstract | Full Text ALLOGRAFTING A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes F Locke, R Agarwal, R Kunnavakkam, K van Besien, R A Larson, O Odenike, L A Godley, H Liu, M M Le Beau, S Gurbuxani, M J Thirman, D Sipkins, C White, A Artz and W Stock Bone Marrow Transplant 2013 48: 1437-1443; advance online publication, June 17, 2013; 10.1038/bmt.2013.79 Abstract | Full Text AUTOGRAFTING Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone A D Sung, D T Grima, L M Bernard, S Brown, G Carrum, L Holmberg, M E Horwitz, J L Liesveld, J Kanda, B McClune, P Shaughnessy, G J Tricot and N J Chao Bone Marrow Transplant 2013 48: 1444-1449; advance online publication, June 10, 2013; 10.1038/bmt.2013.80 Abstract | Full Text POST-TRANSPLANT COMPLICATIONS Duration of first remission, hematopoietic cell transplantation-specific comorbidity index and patient age predict survival of patients with AML transplanted in second CR F V Michelis, E G Atenafu, V Gupta, D D Kim, J Kuruvilla, A Lambie, J H Lipton, D Loach and H A Messner Bone Marrow Transplant 2013 48: 1450-1455; advance online publication, May 20, 2013; 10.1038/bmt.2013.71 Abstract | Full Text Incidence and risk factors for hypogammaglobulinemia in pediatric patients following allo-SCT H Frangoul, E Min, W Wang, R Chandrasekhar, C Calder, M Evans, B Manes, K Bruce, V Brown, R Ho and J Domm Bone Marrow Transplant 2013 48: 1456-1459; advance online publication, May 27, 2013; 10.1038/bmt.2013.76 Abstract | Full Text Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT P J A de Pagter, R Schuurman, L Keukens, M Schutten, J J Cornelissen, D van Baarle, E Fries, E A M Sanders, M C Minnema, B R van der Holt, E Meijer and J J Boelens Bone Marrow Transplant 2013 48: 1460-1464; advance online publication, June 17, 2013; 10.1038/bmt.2013.78 Abstract | Full Text Reduced PTLD-related mortality in patients experiencing EBV infection following allo-SCT after the introduction of a protocol incorporating pre-emptive rituximab W J F M van der Velden, T Mori, W B C Stevens, A F J de Haan, F F Stelma, N M A Blijlevens and J P Donnelly Bone Marrow Transplant 2013 48: 1465-1471; advance online publication, June 10, 2013; 10.1038/bmt.2013.84 Abstract | Full Text Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT J El-Cheikh, G Venton, R Crocchiolo, S Fürst, C Faucher, A Granata, C Oudin, D Coso, R Bouabdallah, N Vey, S Duran, E Fougereau, P Berger, C Chabannon and D Blaise Bone Marrow Transplant 2013 48: 1472-1477; advance online publication, June 10, 2013; 10.1038/bmt.2013.87 Abstract | Full Text Letters to the Editor Top Clinical evidence implicating gamma-delta T cells in EBV control following cord blood transplantation L Farnault, J Gertner-Dardenne, F Gondois-Rey, G Michel, H Chambost, I Hirsch and D Olive Bone Marrow Transplant 2013 48: 1478-1479; advance online publication, July 8, 2013; 10.1038/bmt.2013.75 Full Text Successful second autologous engraftment after long duration storage of hematopoietic stem cells P Longoni, M Milanesi, M Di Nicola, L Devizzi, M Carrabba, F Arienti, F Ravagnani, C Tarella, V Montefusco, A Gianni, P Corradini and M Magni Bone Marrow Transplant 2013 48: 1480-1481; advance online publication, May 27, 2013; 10.1038/bmt.2013.81 Full Text Importance of factors influencing the decision to proceed with cord blood transplantation in adults: results of a web-based survey of the Canadian transplant community J Y S Chan, J Tay and D S Allan Bone Marrow Transplant 2013 48: 1482-1483; advance online publication, June 3, 2013; 10.1038/bmt.2013.85 Full Text Allogeneic SCT for patients with high-risk peripheral T-cell lymphoma in first response M Robles, S Vigouroux, R Tabrizi, K Bouabdallah, M-S Dilhuydy, M Parrens, T Leguay, A Pigneux, P-Y Dumas, A Lascaux, C Duclos, G Marit and N Milpied Bone Marrow Transplant 2013 48: 1484-1485; advance online publication, June 3, 2013; 10.1038/bmt.2013.86 Full Text Outcomes of EAM conditioned autologous haematopoietic SCT for lymphoma. A matched pairs retrospective single-centre study analysis J Loke, J Ward, P Mahendra, S Chaganti and R Malladi Bone Marrow Transplant 2013 48: 1486-1487; advance online publication, June 10, 2013; 10.1038/bmt.2013.90 Full Text Corrigendum Top Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML C Ustun, A C Wiseman, T E DeFor, S Yohe, M A Linden, B Oran, M Burke, E Warlick, J S Miller and D Weisdorf Bone Marrow Transplant 2013 48: 1488; 10.1038/bmt.2013.161 Full Text Advertisement Hot off the press!! Did you know this article from British Journal of Cancer recently appeared in the press?  Leukaemia in young children in the vicinity of British nuclear power plants: a case - control study J F Bithell, M F G Murphy et al.    Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.